Cancer Therapeutics

Logo Benzinga
Business / FinanceBy Globe Newswire2023-03-21 12:00:00
Clinical update of allo-iNKTs (agenT-797) in solid tumors to be presented at AACR Annual Meeting in April 2023 AgenT-797 in combination with pembro or nivo...

Logo Benzinga
Business / FinanceBy Business Wire2023-03-21 12:05:00
-- Liver cancer is a leading cause of death globally, accounting for over 800,000 deaths annually -- GPC3 is selectively overexpressed in a meaningful subset...

Logo GlobeNewswire
SciencePress Release2023-03-21 20:10:00
Received U.S. Food and Drug Administration(FDA) acceptance of Investigational New Drug (IND) application for CUE-102 in Wilms Tumor 1 (WT1)-expressing...

Logo GlobeNewswire
SciencePress Release2023-03-21 07:00:00
LIfT BioSciences a nnounces breakthrough preclinical data demonstrat ing the dual mode of action commonly believed necessary for curing solid tumours IMANp...

Logo EIN Presswire
HealthPress Release2023-03-20 15:20:38
Cancer Therapeutics Market 1 PORTLAND, OR, UNITED STATE, March 20, 2023 / EINPresswire.com / -- Cancer Therapeutics Market - Global Outlook and Forecast...

Logo PR Newswire
HealthPress Release2023-03-21 14:01:00
NOIDA, India, March 21, 2023 /PRNewswire/ -- According to a new report published by UnivDatos Markets Insights, the Advanced Therapy Medicinal Products CDMO...

Logo GlobeNewswire
SciencePress Release2023-03-21 12:30:00
The study is intended to assess whether pepinemab can reverse the suppressive tumor microenvironment found in PDAC, thereby facilitating the anti-tumor...

Logo GlobeNewswire
SciencePress Release2023-03-21 11:30:00
CAMBRIDGE, Mass., March 21, 2023 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on...

Logo GlobeNewswire
SciencePress Release2023-03-21 11:31:00
ACTengine IMA203 TCR-T monotherapy against PRAME showed 50% confirmed objective response rate (cORR) at or above target dose in different solid cancers in an...

Logo PR Newswire
SNAP-CAR recognized in research detailing advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and...

Logo Benzinga
Business / FinanceBy Business Wire2023-03-21 15:10:00
Results provide rationale for combining modern needle-free administration and plasmid DNA vaccines and therapeutics. PharmaJet, a company engineering...

Logo Benzinga
Business / FinanceBy Pr Newswire2023-03-21 13:05:00
Author says aggressive cancer treatments and invasive surgical procedures were made tolerable by his physical drive, strong mindset, and spiritual connection...

Logo GlobeNewswire
HealthPress Release2023-03-20 10:00:00
Company anticipates that the c ombination of pan-TKI dovitinib and PARP inhibitor stenoparib may generate synergistic anti-cancer activity Program initiation...

Logo GlobeNewswire
SciencePress Release2023-03-21 11:30:00
BOSTON, March 21, 2023 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), an immuno-oncology company focused on the discovery and development...

Logo Benzinga
Business / FinanceBy Pr Newswire2023-03-20 14:03:00
After traveling the world interviewing medical professionals, alternativehealth experts, commentators, whistleblowers, and physiciansto document the many...

Logo U.S. News & World Report
PoliticsBy Health Day2023-03-21 15:35:00
By Cara Murez HealthDay Reporter TUESDAY, March 21, 2023 (HealthDay News) -- An ongoing shortage of a drug for men with advanced prostate cancer is causing...

Logo Benzinga
Business / FinanceBy Business Wire2023-03-21 04:05:00
Prestige Biopharma has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for PBP1510 (International Non-proprietary name:...

Logo GlobeNewswire
HealthPress Release2023-03-21 21:15:00
EAGAN, Minn., March 21, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI),a science-driven company leveraging its proprietary artificial...

Logo Benzinga
Business / FinanceBy Globe Newswire2023-03-21 12:46:37
LIfT BioSciences a nnounces breakthrough preclinical data demonstrat ing the dual mode of action commonly believed necessary for curing solid tumours London,...